Approach to Dyslipidemia Among Diabetic Patients Farzad Hadaegh 98

Approach to Dyslipidemia

Among Diabetic Patients

Farzad Hadaegh, MD

Prevention of Metabolic Disorders Research Center

Research Institute for Endocrine Sciences

Shahid Beheshti University of Medical Sciences

Tehran, Jul 2019

50. Overview of dyslipidemia among Tehranian diabetic population
50. Definition and pathophysiology of diabetic dyslipidemia
50. Statin therapy in diabetic patients
50. Residual risk and add on statin therapy(ezetimibe , highly purified omega 3 and PCSK9 inhibotors) in individuals with diabetes mellitus
50. Guideline (ADA/2019, AHA/2019)
50. Take home message
50. Aims/Hypothesis: To investigate secular trends in cardiovascular disease (CVD) risk factors during a decade of follow-up in a Middle Eastern cohort, and to compare observed trends between diabetic and non-diabetic populations.
50. Methods: In a population of 6181 participants (2622 males and 3559 females), diabetes status and CVD risk factors were evaluated in 4 study phases from 1999– 2011. 1045 subjects had type 2 diabetes mellitus at baseline and 5136 participants were diabetes-free.